Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline
- Guideline Contact
- guidelines@asco.org
- Publication Date
- 29-Jul-21
- Date of Last Evidence Search
- 13-May
- Countries of Application
- United States
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- ASCO (US)
- Publication Year
- 2021